Podcasts about Cart

In this episode of The Influence Factor, Alessandro Bogliari speaks with Courtney Weis, Managing Director of Brand Marketing at FP Movement. Their conversation explores the brand's commitment to empowering women through activewear, the vital role of community involvement, and the dynamic shifts within influencer marketing. Courtney offers valuable perspectives on FP Movement's collaborations with athletes and creators, highlights the power of storytelling in brand marketing, and provides a preview of the brand's upcoming campaigns and activations.

This week we revisit Sherry Cola stepping straight out of the big screen into the Add to Cart universe. The “JOY RIDE” actress reflects on the importance of seeing Asian women fully represented as their wild, raunchy and hilarious selves. In the spirit of being true to yourself, Sherry dishes on her favorite Asian snacks and why her Hello Kitty subscription box is self-care. She also shares how she’s finding her zen, and why she’s removing from cart saying “yes” (but not to this podcast!) Please note, Add To Cart contains mature themes and may not be appropriate for all listeners. To see all products mentioned in this episode, head to @addtocartpod on Instagram. To purchase any of the products, see below. Sherry is healing her inner childhood with the Hello Kitty subscription box Her fave Asian snacks now are IRVINS Salted Egg Potato Chips Crisps and the classic wasabi peas ATC faves are Chingoo snacks and Loaf Language JOY RIDE is in theaters now! Randall Park’s movie Shortcomings (starring Sherry Cola) will be in theaters August 4 Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia. Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium. Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: lemonadamedia.com/sponsorsSee omnystudio.com/listener for privacy information.

This month, the gals are visited by Cassidy Liston from Drinking the Koolaid Podcast to discuss gull shrieking, mystery man meats, angel eggs, red-wing red flags, crystal-encrusted corpses, and a suspiciously bound book. Tune in for May's episode of Gossip at the Corpse Cart! For a full list of show sponsors, visit https://wineandcrimepodcast.com/sponsors. To advertise on Wine & Crime, please email ad-sales@libsyn.com or go to advertising.libsyn.com/winecrime.  

Dr. Jack Cush reviews the news and journal reports from RheumNow.com - including views on the vagus nerve, NPSLE and CAR-T mania.  

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Adriana Herrera, CEO at Pierre Fabre Pharmaceuticals (USA). Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adriana, covering: Why Big Pharma is such a great training ground for future pharma leaders, and how a period living and working in Mexico defined her leadership style The reality of being purchased by a big pharma like Gilead, and retaining independence as the acquired company, Kite Pharma The opening of a market opportunity that led Adriana to her first CEO role, and how the role is pushing her outside of her comfort zone Why she is optimistic about the future of manufacturing and commercialising cell therapies - innovation will find a way, but it takes time How the current geopolitical environment is adding more risk and uncertainty to an industry plagued with risk... and how that may impact investments and supply chains Adriana leads the expansion of Pierre Fabre's US presence in precision oncology, cell therapy and rare diseases with an immediate focus on the commercialization of a groundbreaking allogenic cell therapy. Most recently, Adriana served as U.S. General Manager at Kite Pharma where she successfully commercialized the autologous CART-cell therapy portfolio and led the US commercial functions. Prior to that, her experience included a tenure at Eisai as Senior Vice President and commercial head for U.S. Oncology and high-impact leadership roles at Novartis Oncology including Vice President and Global Diseases Lead for Lung and Genitourinary cancers. Adriana commenced her career at Bristol Myers-Squibb. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.

In this modern day we are all used to buying a game and having to wait for the updates to download before we can actually play it. But what if your internet is down and you can't download that update, or you can't download the other 90% of the game so you can actually play it? Well that will be the case most of the time, but there are exceptions! Come join Rob, James and myself as we talk about the world of cart revisions on the Nintendo Switch!

Mike Shorr with @ProsperTradingAcademy focuses on three companies with expansive reach in ecommerce and digital advertising. He notes Maplebear (CART) brushing up against a key resistance level, Roku Inc.'s (ROKU) vulnerability of "outperforming to the downside," and his bullish expectations on Amazon (AMZN). Rick Ducat takes a deeper look at the technical trends his sees in the charts.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – / schwabnetwork Follow us on Facebook – / schwabnetwork Follow us on LinkedIn - / schwab-network About Schwab Network - https://schwabnetwork.com/about

Host: Denise M. Dupras, M.D., Ph.D. Guest: Saad J. Kenderian, M.B., Ch.B. Dr. Saad Kenderian discusses the use of CAR-T cell therapy, a groundbreaking treatment that genetically modifies a patient's T-cells to target and destroy cancer cells, particularly in blood cancers like leukemia and lymphoma. He highlights the importance of identifying eligible patients, monitoring treatment response, and applying genomics to guide the future of personalized cancer immunotherapy. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

We love to hear from our listeners. Send us a message.Host Erin Harris talks to Generate:Biomedicines' EVP of R&D, Dr. Alex Snyder about the convergence of AI, machine learning (ML), and synthetic biology in the development of next-generation therapies. They cover how AI is transforming drug discovery by enabling the rapid design and optimization of therapeutic candidates, particularly in complex fields like immuno-oncology and cell therapy. Dr. Snyder shares how that in the context of CAR-T therapies, AI-driven approaches are used to design and refine each component of the CAR construct. And, Dr. Snyder sets the stage for a broader conversation about how the integration of AI and synthetic biology is not only accelerating drug development timelines but also expanding the realm of what's possible in cell-based therapeutics.Subscribe to the podcast!Apple | Spotify | YouTube

With more adults living longer, oncology is facing a critical challenge: how to provide cancer care that reflects the realities of aging. In this episode, Dr. Dale walks us through the creation of SOCARE (Specialized Oncology Care and Research in Elders), a clinic that evaluates patients' physical function, cognitive health, and social environment before treatment begins. This kind of assessment leads to better decisions, fewer complications, and care that aligns with each person's capacity and goals.We also talk about the OASIS program, which extends this approach across disciplines, bringing in nurses, pharmacists, and social workers to create a more coordinated experience for patients. Throughout the conversation, Dr. Dale shares real examples and lessons from the field, showing how geriatric oncology can improve not just outcomes, but the entire care process.Episode Highlights:A fresh look at what defines “fitness” for cancer treatment — and why age alone isn't enoughHow SoCare creates space for longer, more thoughtful patient conversationsPractical examples of tailoring chemotherapy, transplant, and CAR T plans for older adultsInsights into building trust with patients and providers through individualized care Resources & LinksCity of Hope – Center for Cancer and Aging: cityofhope.orgASCO Geriatric Oncology Guidelines: asco.org

In this week's episode we'll learn about how frequent blood donation affects clonal hematopoiesis in older, male blood donors; the effect of immune microenvironment on response to bispecific antibodies in diffuse large B-cell lymphoma; and the feasibility of adding blinatumomab to early consolidation therapy in CD19-positive Ph-negative B-cell acute lymphoblastic lymphoma.Featured ArticlesClonal Hematopoiesis Landscape in Frequent Blood DonorsIntegrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody responseUpfront Blinatumomab Improves MRD Clearance and Outcome in Adult Ph-negative B-lineage ALL: The GIMEMA LAL2317 Phase 2 Study

In part two of the How I Treat Series on Transfusion Medicine Dr. Erica Wood interviews the "How I Manage Major Hemorrhage" author group: Drs. Jeannie Callium, Keyvan Karkouti, and Ron George.Find the full published review series in Volume 145 Issue 20 of Blood Journal.

In this episode, I share the biggest lessons I've learned from experimenting with every business model imaginable over the past eight years. If you've ever wondered why a business model that works brilliantly for someone else feels completely exhausting for you, this episode reveals exactly why - and what to do about it.What You'll Learn:

Today's VJHemOnc podcast features discussions from the 7th International Workshop on CAR-T and bispecifics (iwCAR-T) 2025, which was held recently... The post Highlights from iwCAR-T 2025: improving the efficacy and safety of CAR T-cells & access in the community appeared first on VJHemOnc.

In the latest in our Evercade cart-by-cart series Chris W, Chris O and Jim take a look at the games of Atari Collection 2. As always, thanks to all of our Patreon's who made this episode possible, we really appreciate your kind donations! Guy Simms  Richard Hyde kingdiesel Roger Swan Plasticman Stephen James Cillian O'Brien Robert Ilott MrRockitt Pete Rogers Rune P New Game Old Flame - Podcast Christopher Bolton Damon Crockett Dylan D'Arch Bitmap Soft Mikes vintage Tech Nik, Howard Price Matthew Turner Adam Hinde Chris O'Regan James Dunn Hans aka Muppets4 Roushimsx  Guto Threadbare Chris Atwill Harvey Watson Martyn Jones Tim TJ Walker Ricardo Engel HeavyMetalDon Tony Parkinson drnovocalcord Mal Woods Cane and Rinse LamptonWorm  Mitsoyama Rhys Wynne Clint Humphrey Mark Bylund Paul Ashton Jon Sheppard Laurent Giroud Deadl0ck Aaron Maupin Jim-OrbitsIT Jon Veal Thomas scoffham Patrick Fürst Laurens Andrew Gilmour Stephen Stuttard Darren Coles Garry Heather Nick Lees Blake Brett Looking for some MiSTer FPGA accessories? Give https://misterfpga.co.uk/ a visit and use the code retroasylum to gain a 6% discount. Want to find out about Steve's band, The Last Arcade? Check them out at https://thelastarcade.net/ Looking for some new games for your favourite retro system? Then checkout https://www.bitmapsoft.co.uk/ Help support the Retro Asylum by becoming a patron: https://www.patreon.com/retroasylum Retro Asylum on BlueSky: https://bsky.app/profile/theretroasylum.bsky.social Retro Asylum on Facebook: https://www.facebook.com/retroasylum/ Retro Asylum YouTube Channel: https://www.youtube.com/channel/UCfCC9rIvCKoW3mdbuCsB7Ag Retro Asylum on Instagram: https://www.instagram.com/the_retro_asylum/ Retro Asylum on Twitch:https://www.twitch.tv/theretroasylum Twitter: @theretroasylum Retro Asylum Merchandise: https://retroasylumstore.myspreadshop.co.uk/  

The Story of the Broadcast Cart Machine is fascinating, especially to those of us who used them on-air, or installed and repaired them as engineers. Andy Rector, who was heavily involved in the business of broadcast cart machines, joins us for Part 2 of our exploration into this history. We’ll go through the 1970s and 1980s, as new broadcast cart machines were developed and deployed. We’ll follow this story arc right up to the late 1990s, when Andy says was really the end of that cart machine era. Show Notes:An Afternoon with John “Jack” Mullin - A video by the Audio Engineering Society Guest:Andy Rector - Broadcast Equipment HistorianHost:Kirk Harnack, The Telos Alliance, Delta Radio, Star94.3, South Seas, & Akamai BroadcastingFollow TWiRT on Twitter and on Facebook - and see all the videos on YouTube.TWiRT is brought to you by:Broadcasters General Store, with outstanding service, saving, and support. Online at BGS.cc. Broadcast Bionics - making radio smarter with Bionic Studio, visual radio, and social media tools at Bionic.radio.Aiir, providing PlayoutONE radio automation, and other advanced solutions for audience engagement.Angry Audio and the new Rave analog audio mixing console. The new MaxxKonnect Broadcast U.192 MPX USB Soundcard - The first purpose-built broadcast-quality USB sound card with native MPX output. Subscribe to Audio:iTunesRSSStitcherTuneInSubscribe to Video:iTunesRSSYouTube

The Investing Power Hour is live-streamed every Thursday on the Chit Chat Stocks Podcast YouTube channel at 5:00 PM EST. This week we discussed:(02:27) Exploring Nu Bank's Growth and Market Potential(09:04) Instacart's Business Model and Market Position(16:50) Airbnb's New Services and Market Strategy(33:41) Challenges Facing UnitedHealth and Industry Insights(36:05) UnitedHealth's Turmoil and Market Reactions(41:21) Bubble Watch: Basic Capital's Risky Leverage(48:39) Earnings Insights and Market Trends(57:57) AI in Commerce: Trusting Technology for Purchases(01:01:34) Chime's IPO: A Potential Investment Opportunity*****************************************************JOIN OUR NEWSLETTER AND CHAT COMMUNITY: https://chitchatstocks.substack.com/ *********************************************************************Chit Chat Stocks is presented by Interactive Brokers. Get professional pricing, global access, and premier technology with the best brokerage for investors today: https://www.interactivebrokers.com/ Interactive Brokers is a member of SIPC. *********************************************************************FinChat.io is The Complete Stock Research Platform for fundamental investors.With its beautiful design and institutional-quality data, FinChat is incredibly powerful and easy to use.Use our LINK and get 15% off any premium plan: ⁠https://finchat.io/chitchat *********************************************************************Bluechippers Club is a tight-knit community of stock focused investors. Members share ideas, participate in weekly calls, and compete in portfolio competitions.To join, go to ⁠Blue Chippers and apply! Link: ⁠https://bluechippersclub.com/*********************************************************************Disclosure: Chit Chat Stocks hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation.

The Story of the Broadcast Cart Machine is fascinating, especially to those of us who used them on-air, or installed and repaired them as engineers. Andy Rector, who was heavily involved in the business of broadcast cart machines, joins us for Part 2 of our exploration into this history. We'll go through the 1970s and 1980s, as new broadcast cart machines were developed and deployed. We'll follow this story arc right up to the late 1990s, when Andy says was really the end of that cart machine era.

In this week's episode, we'll learn about stopping myeloma maintenance therapy in the modern era. New research suggests that many patients in remission can discontinue lenalidomide, remaining treatment-free, without jeopardizing disease response. After that: a novel congenital neutropenia syndrome. Mutations in the COPZ1 gene impact myeloid differentiation and development of neutropenia. Researchers describe the mechanisms and propose a treatment strategy for restoring granulopoiesis. Finally, ruxolitinib maintenance therapy after allogeneic transplant. In a phase 2 study, this treatment strategy was associated with low rates of chronic graft-versus-host disease. Investigators say the use of JAK inhibitors in this context warrants further study.Featured Articles: Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myelomaA new severe congenital neutropenia syndrome associated with autosomal recessive COPZ1 mutationsLow rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT

In this two-part series, Dr. Erica Wood talks with Drs. Masja de Haas, Helen Savoia, and Stella Chou about their articles in the How I Treat Series on Transfusion Medicine. Topics include noninvasive prenatal testing for red blood cell and platelet antigens, transfusion cases in sickle cell disease, and pregnant patients who are alloimmunized to RBC antigens. Find the full published review series in Volume 145 Issue 20 of Blood Journal.

Hematology-oncology physician Yousuf Zafar discusses his article, "The personalization of cancer care in 2025." He traces the evolution of cancer treatment over the past two decades, moving through waves of cytotoxic chemotherapy, biologic therapies, immunotherapies including groundbreaking CAR-T therapy, and now precision oncology, which targets treatments to the specific molecular profile of a patient's cancer. While these advancements have significantly improved survival and quality of life, Yousuf highlights the resulting increase in care complexity and the widening gap in outcomes between specialized centers (where only 20 percent of U.S. patients are treated) and community practices (where 80 percent of care occurs), particularly impacting rural areas where 66 percent of counties lack an oncologist. The conversation explores how digital health solutions, such as remote case reviews connecting community oncologists with subspecialists, can help bridge this divide and improve access. Importantly, Yousuf stresses that personalized care extends beyond treatment to encompass vital patient support for financial burdens, mental well-being, and survivorship. Actionable takeaways emphasize the need for collaboration, resources for community oncologists, investment in digital health tools, and a continued focus on patient-centered support throughout the cancer journey. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise—and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Cancer is among the most common and feared diseases in the modern world. Dr. Selwyn Vickers—president and CEO of Memorial Sloan Kettering Cancer Center—joins host Mark Labberton to discuss how precision oncology, data, and faith are transforming cancer treatment. A distinguished cancer surgeon and pancreatic cancer researcher, Vickers explains how groundbreaking advances in genomics, immunotherapy, and AI are transforming once-lethal diagnoses into survivable and even chronic conditions. Together, they explore not only the cutting-edge science of cancer care but also the spiritual, emotional, and social dimensions that affect every patient and caregiver. Resonating with themes of suffering, hope, and resurrection, this conversation offers clarity, compassion, and courage for all who are affected by cancer—from those newly diagnosed, to medical professionals, to grieving families and curious listeners. Episode Highlights “We're getting to a point where we will, in the next five to seven years, have a much better chance to cure people—and to make pancreatic cancer a chronic illness.” “We are in what's somewhat coined the golden age of cancer research.” “Cancer is a disease that creates an existential threat in ways no other illness does.” “If a tumour forms, it means your body's immune system has made a social contract with the cancer.” “We changed the diagnosis in 10–12 percent of the patients who come to us—sometimes from cancer to no cancer.” “Cancer care is a team sport. And our patients often inspire us more than we help them.” Helpful Links & Resources Memorial Sloan Kettering Cancer Center BioNTech – creators of mRNA vaccines for COVID and cancer CAR T-Cell Therapy Overview (Cancer.gov) Tim Keller on cancer and hope Emma Thompson's Wit (HBO) BRCA1 and BRCA2 Genes and Cancer Risk MSK-IMPACT: Next-Gen Tumor Profiling About Selwyn Vickers Selwyn M. Vickers, MD, FACS, is the president and CEO of Memorial Sloan Kettering Cancer Center (MSK) and the incumbent of the Douglas A. Warner III Chair. He assumed the role on September 19, 2022. Vickers is an internationally recognized pancreatic cancer surgeon, pancreatic cancer researcher, and pioneer in health disparities research. He is a member of the National Academy of Medicine and the Johns Hopkins Society of Scholars. He has served on the Johns Hopkins School of Medicine Board of Trustees and the Johns Hopkins University Board of Trustees. Additionally, he has served as president of the Society for Surgery of the Alimentary Tract and the Southern Surgical Association. Vickers is the immediate past president of the American Surgical Association. He also continues to see patients. In 1994, he joined the faculty of the University of Alabama at Birmingham (UAB) as an assistant professor in the Department of Surgery, where he was later appointed to professor and the John H. Blue Chair of General Surgery. In 2006, Vickers left UAB to become the Jay Phillips Professor and Chair of the Department of Surgery at the University of Minnesota Medical School. Born in Demopolis, Alabama, Vickers grew up in Tuscaloosa and Huntsville. He earned baccalaureate and medical degrees and completed his surgical training (including a chief residency and surgical oncology fellowship) at the Johns Hopkins University. Vickers completed two postgraduate research fellowships with the National Institutes of Health and international surgical training at John Radcliffe Hospital of Oxford University, England. Vickers and his wife, Janice, who is also from Alabama, have been married since 1988. They have four children. Show Notes The ongoing threat and fear of cancer How Selwyn Vickers got into medicine Pancreatic cancer: Vickers's expertise “We are in what's somewhat coined the golden age of cancer research.” Sequencing the human genome “Is there a drug that might target the mutation that ended up creating your cancer?” Cancer as both a medical and existential diagnosis The revolution of precision oncology through human genome sequencing ”It takes a billion cells to have a one centimetre tumor.” Immunotherapy: checkpoint inhibition, CAR T-cell therapy, and vaccines Cellular therapy:   ”Taking a set of their normal cells and re-engineering them to actually go back and target and attack their tumors. … We've seen patients who had initially a 30 percent chance of survival converted to an 80 percent chance of survival.” “We know in many tumours there's something called minimal residual disease.” “Immunizing yourself against cancer is a significant future opportunity.” Managing the power of data with AI and computational oncology Cancer-care data explosion: the role of computational oncologists Cancer vaccines: breakthrough mRNA treatment for pancreatic cancer ”Didn't ultimately win. We had to suffer through her losing her life, but was so appreciative that she got much more than the six months she was promised.” Tumour misdiagnoses and the importance of specialized expertise Pancreatic cancer challenges: immune cloaking and late-stage detection In the past, one in four would die from the operation for removing pancreatic cancer Long-term survival Future of cancer detection: AI-based medical record analysis and blood biopsies More accurate blood tests to confirm conditions Using AI to select those who are high-risk for cancer Pastor Tim Keller died of pancreatic cancer. In the past, “your doctor … helped you learn how to die.” ”[God's] given man the privilege to discover those things that have been hidden. And over time we've gradually uncovered huge opportunities to impact people's lives.” The state of breast cancer research and treatment “If you get the diagnosis of breast cancer, you have a 90 percent chance to survive and beat it over a five-year period of time.” ”In general, we're in a great state of understanding how to treat breast cancer, how to detect it early, and then have selective and targeted mechanisms to prevent it from coming back.” Prostate cancer research and treatment Theranostics: using a specific antibody to target cancer cells specifically Pediatric cancer:  ”We actually treat more children for cancer than any hospital in America now, but in general, the survival for pediatric cancers is greater than 80 percent.” Emotional, psychological, and spiritual toll of cancer: importance of psycho-oncology How Sloan Kettering developed psycho-oncology to help cancer patients with mental and spiritual health Personal story: how a cafeteria worker empowers patients through food choices “We give back to them the right to choose what they get to have on their tray.” Cancer treatment is a team sport. Wit (film, Broadway play)—actress Emma Thompson plays a cancer patient studying the work of John Donne on death Socioeconomic and racial disparities in cancer care outcomes The healing role of community, support teams, and compassionate listening The importance of listening to cancer patients who are preparing to die The spiritual courage of patients and the transformative power of faith “Our patients often help us. We see the grace with which they often handle that journey.” The inspiration behind becoming a doctor: family legacy and human impact Terminal care: the sacred responsibility of walking with patients to the end Cancer research and treatment as a Christian vocation and expression of humanity Production Credits

Austin duo Felt Out (FKA “Emme” for you fellow 2010’s Austin music scenesters) mesmerize and catch audiences off-guard with their signature blend of kitchen-sink alt-pop — no sound or notion is off-the-table, one song can be metallic and the next quite earthy, with maybe a guitar as a shared element. But the infinitely-instrumentalist duo are […] The post Felt Out: “Fruit Cart” appeared first on KUT & KUTX Studios -- Podcasts.

CAR T-cell therapy is giving hope to cancer patients around the world. While not currently available in New Zealand, a clinical trial is underway at Wellington's Malaghan Institute.

In a conversation with CancerNetwork®, Viviana Cortiana, MS4, medical student in the Department of Medical and Surgical Sciences at the University of Bologna, and Yan Leyfman, MD, a resident physician from the Icahn School of Medicine of the Mount Sinai Health System, discussed their publication in the March 2025 issue of ONCOLOGY titled “Expanding horizons in T-cell lymphoma therapy: a focus on personalized treatment strategies.” Throughout the discussion, the authors spoke about the current lymphoma landscape, CAR T-cell therapy, and the evolving understanding of the tumor microenvironment. Specifically, Cortiana covered a shift from histology-based classification to molecular tumor type classification using next-generation sequencing, as well as a growing interest in biomarker-driven therapies. Regarding the limited efficacy of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in T-cell lymphoma, she listed potential advances in combination therapies for angioimmunoblastic T-cell lymphoma (AITL), which include combining P13K and HDAC inhibition as well as CD30- and TRBC1-targeting CAR T-cell therapies. Furthermore, Leyfman discussed strategies that “reprogram” the microenvironment to address malignant T cells, particularly through epigenetic and adoptive cell therapies. Leyfman concluded by discussing future implications for T-cell lymphoma treatment, emphasizing an emergence of precision medicines and armored CAR engineering strategies. Authors of the manuscript published in ONCOLOGY outlined the available treatment options for peripheral T-cell lymphoma (PTCL), which include targeted therapies through EZH2 inhibition, chemotherapy with CHOP, CAR T-cell therapies, and allogenic stem cell transplantation. Additionally, they highlighted encouraging results from clinical trials evaluating epigenetic-targeted therapies through the identification of molecular aberrations, which can help tailor treatments to individual patients.  Furthermore, the article explored limitations of chemotherapy as well as autologous stem cell transplantation (ASCT), which may not be feasible for older patients or those with comorbidities. Authors suggested that targeted therapies may enhance tumor specificity while reducing systemic toxicity. Given the risks associated with ASCT, they emphaisized a focus on the incorporation of optimized treatment strategies, such as novel pharmaceuticals and combination therapies, into clinical practice for patients with PTCL.

Uma bandeira de cartões, uma fintech ou uma empresa de tecnologia? O episódio #212 do programa Mídia e Marketing recebe Carla Mita, vice-presidente de marketing da Visa no Brasil. A conversa aborda a evolução do posicionamento da Visa, que nasceu como uma empresa de cartões e hoje se define como uma companhia de tecnologia. Carla também discute as estratégias de marketing da marca, como a personalização da experiência do cliente, a criação de momentos memoráveis por meio de patrocínios esportivos e a adaptação da comunicação para alcançar novas gerações.

In the latest episode from the JBP the crew discusses their plans for Kendrick Lamar's next show (8:40) before turning to the allegations that came out earlier this week against Smokey Robinson (38:22) as well as former Laker Byron Scott (49:21). Joe informs the room of Tyler Chase Butler's story after hus arrest in Virginia (1:00:04) and then shares his thoughts about the New York Knicks who are coming home up 2-0 against Boston (1:13:24). Also, the JBP family has an intervention for Marc Lamont Hill after his latest appearance on Piers Morgan's show (1:48:48), rumors of UNC banning Bill Belichik's girlfriend from their facilities (2:20:55), the BET Awards nominations for 2025 (2:45:06), and much more!  Become a Patron of The Joe Budden Podcast for additional bonus episodes and visual content for all things JBP! Join our Patreon here: http://www.patreon.com/joebudden  Sleeper Picks:  Joe | Davido (feat. Omah Lay) - “With You” Ice | Don Trip and Starlito - “Madden Curse” Parks | Lefty Gunplay, JasonMartin, & The Game - “MENACE” Ish | Reggie Becton - “All In” Melyssa | Jessie Reyez - “**CUDN'T B ME**” Marc | Kindred the Family Soul - “Far Away”

Curious about CAR T-cell therapy? We went straight to the source for answers. In this episode, the LLS Patient Education… The post CAR T-cell Therapy: Your Questions Answered first appeared on The Bloodline with LLS.

Most of us in radio engineering have worked with broadcast cart machines. While it’s been a good 25 or 30 years since we’ve had them in our studios, we’ll never forget the pleasure - and occasional pain - of using them and maintaining them. But how did cart machines come to be? Were they always like the ones we grew up with in the 70s and 80s? Or did the development come with fits and starts? Andy Rector worked with broadcast carts nearly from the very beginning of their existence. He’s been interviewed many times and provided historical presentations to SBE groups, AES sections, and others. We’re delighted to have Andy Rector join us on this TWiRT episode to look at the early days of broadcast cart machines and the early technologies employed. Show Notes:These Were the Carts of Our Lives - Radio World article Guest:Andy Rector - Broadcast Equipment HistorianHosts:Chris Tarr - Group Director of Engineering at Magnum MediaKirk Harnack, The Telos Alliance, Delta Radio, Star94.3, South Seas, & Akamai BroadcastingFollow TWiRT on Twitter and on Facebook - and see all the videos on YouTube.TWiRT is brought to you by:Broadcasters General Store, with outstanding service, saving, and support. Online at BGS.cc. Broadcast Bionics - making radio smarter with Bionic Studio, visual radio, and social media tools at Bionic.radio.Aiir, providing PlayoutONE radio automation, and other advanced solutions for audience engagement.Angry Audio and the new Rave analog audio mixing console. The new MaxxKonnect Broadcast U.192 MPX USB Soundcard - The first purpose-built broadcast-quality USB sound card with native MPX output. Subscribe to Audio:iTunesRSSStitcherTuneInSubscribe to Video:iTunesRSSYouTube

La deuxième heure en intégralité de l'émission « Rothen s'enflamme », le rendez-vous qui vous plonge dans un vestiaire de foot. Tous les soirs, des anciens joueurs professionnels analysent et débattent autour de l'actualité du foot. Jérôme Rothen anime des

Most of us in radio engineering have worked with broadcast cart machines. While it's been a good 25 or 30 years since we've had them in our studios, we'll never forget the pleasure - and occasional pain - of using them and maintaining them. But how did cart machines come to be? Were they always like the ones we grew up with in the 70s and 80s? Or did the development come with fits and starts? Andy Rector worked with broadcast carts nearly from the very beginning of their existence. He's been interviewed many times and provided historical presentations to SBE groups, AES sections, and others. We're delighted to have Andy Rector join us on this TWiRT episode to look at the early days of broadcast cart machines and the early technologies employed.

Numa jornada que durou quase um ano e atravessou sete países, um casal e seus dois filhos pequenos imigram em busca de um sonho, que acabou se tornando um pesadelo. Observação aos ouvintes: no episódio Cartões Postais do Fim do Mundo (episódio número 100), a repórter Carol Pires conta uma história correlata à esta. Considere ouvi-la antes ou depois deste aqui. O equilíbrio perfeito entre proteção térmica e leveza existe: é a Tech T-Shirt de manga longa Insider - e ela está com uma promoção imperdível. Para aproveitar, insira o cupom RADIONOVELO ao final da sua compra pelo site: ⁠https://creators.insiderstore.com.br/RADIONOVELO ⁠#insiderstore ⁠Carbono Zero ⁠é um podcast que vai explicar por que precisamos encontrar novas maneiras de produzir e de consumir para evitar que a crise climática se agrave. A cada duas semanas vamos trazer histórias sobre a construção de uma economia diferente: de baixo carbono, que respeita o planeta e as pessoas. Siga o podcast no seu tocador preferido para não perder nenhum episódio. Carbono Zero é uma produção do ⁠Reset⁠, um site de jornalismo independente onde você encontra a melhor cobertura de negócios para uma economia mais justa e sustentável.  Acompanhe a Rádio Novelo no Instagram: https://www.instagram.com/radionovelo/ Siga a Rádio Novelo no TikTok: https://www.tiktok.com/ Palavras-chave: imigração; trump; darién; méxico Learn more about your ad choices. Visit megaphone.fm/adchoices

In this week's episode, we'll learn more about how measurable residual disease might help guide decisions about post-transplant gilteritinib maintenance in FLT3-ITD acute myeloid leukemia, or AML; how stemness contributes to chemotherapy resistance in AML; and effects of babesiosis on red blood cells from individuals with sickle cell disease, sickle cell trait, and wild-type hemoglobin. Featured Articles:Measurable residual disease and post-transplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia Babesiosis and Sickle Red Blood Cells: Loss of Deformability, Heightened Osmotic fragility and Hyper-vesiculation 

Our guest in this podcast episode is lymphoma survivor and CAR-T cell therapy patient advocate, Brad Watts. In this episode, Brad shares his personal story battling lymphoma at the young age of 29 along with his experience receiving an innovative cell therapy. This field is transforming lives and Brad is living proof of this potential.

This week, we're bringing you something special: an episode from Add to Cart, a show we love hosted by Kulap Vilaysack and SuChin Pak. You might remember Kulap when she was a guest on our show back in 2018, where she bravely unpacked her childhood trauma and shared how it led to her documentary film. Add to Cart is a witty, subversive take on consumerism. Each week, Kulap and SuChin have candid (and often TMI) conversations about what they're adding to or removing from their carts—whether it's products, people, trends, or philosophies. Together, they explore what we're buying into and what it reveals about who we are.  In this episode, they're joined by author and journalist Vicky Nguyen for the very first Auntie Book Club of the year, diving into her powerful memoir Boat Baby. Vicky talks about going from boat refugee to national TV and why the R is for refuse in her household. To hear more episodes of Add to Cart, follow the show wherever you get your podcasts or head to: https://lemonada.lnk.to/atcfd … Kulap's LST episode #204 Breaking Cycles (and Chairs!) with Kulap Vilaysack … Join LST+ for community and access to You Know What, another show in the Longest Shortest universe! Follow us on Instagram Website: longestshortesttime.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of The Influence Factor, Alessandro Bogliari speaks with Jennifer Healan, VP of Brand, Content, and Culture at McDonald's US. Jennifer shares her journey leading creative transformation at iconic brands, emphasizing the power of creative bravery, tapping into fan truths, and launching standout campaigns like McDonald's anime collaboration. She also explores the evolving role of influencers, live streaming, and how authenticity and community-building are shaping the future of marketing.

Welcome back, Self-Starters! I've missed you, and we've got LOTS to catch up on. From travels, to wedding season, round 2 of the mastermind, and turning 30!! ✨ We are diving into it all on this casual phone call, chatty catch up. Listen in if you are ready to get back in the know. And stay tuned for some fun episodes soon as the podcast returns!Biggest thing you can do to help me? ⭐️ LEAVE A REVIEW ⭐️ Helps me a ton! And I will certainly make it worth your while. Email or DM me your review for a special thank you! EMAIL: hello@nicholelaurenphotography.comINSTAGRAM: instagram.com/_nicholelaurenMastermind Round 3 is coming this summer!! Only 2 of 5 spots remaining. Learn more and apply HERE!FREE DOWNLOAD: Full-Time Photographer's Playbook (PDF Guide)Special Deals on my FAVS (affiliate links)-* Email Marketing Software: Flodesk (50% off)* Cart & Sales Software: Thrivecart (Lifetime Price)

In May 2025, we attended IMMUNOLOGY2025™, the annual meeting of the American Association of Immunologists in Honolulu, and recorded daily episodes discussing highlights of the previous 24 hours. Here is the third of five special episodes from the meeting. Brenda and Jason discuss highlights from sessions on mucosal immunology and the role of T cells in lactogenesis. They also talk about γδ CAR T cells and veterinary immunology — from sharks to elephants.

Trump lo hizo de nuevo. El presidente de los Estados Unidos anunció abruptamente en Truth Social un arancel del 100% sobre todas las películas “producidas en tierras extranjeras”, aunque no explicó cómo se aplicarían. La noticia generó caos en la industria del cine, en medio de la incertidumbre. Para este lunes, la Casa Blanca salió a decir que no se han tomado decisiones finales sobre este arancel.El gabinete de seguridad de Israel aprobó un nuevo plan militar de gran escala para “conquistar” y retener territorios en Gaza de forma permanente, rompiendo con estrategias anteriores de incursiones temporales.Además… Gutiérrez Luna y Fernández Noroña solicitaron formalmente al INE la cancelación del registro de 26 candidaturas a cargos judiciales; Ya están en Roma los cardenales que elegirán al nuevo papa; El bloque conservador y socialdemócratas de Alemania firmaron el acuerdo para formar gobierno; Ya arrancó el juicio de Sean Combs; Bad Bunny anunció conciertos en CDMX; Y se llevó a cabo el Met Gala 2025.Y para #ElVasoMedioLleno… Una niña con dermatomiositis, una enfermedad autoinmune rarísima, fue tratada con éxito en el Hospital La Paz, de Madrid, usando la terapia CAR-T.Para enterarte de más noticias como estas, síguenos en redes sociales. Estamos en todas las plataformas como @telokwento. Hosted on Acast. See acast.com/privacy for more information.

In today's episode, I had the opportunity to speak with Rafael Carazo Salas, a scientist, entrepreneur, and the CEO and founder of CellVoyant. This is a conversation that goes beyond the hype around AI to reveal how machine learning is reshaping the future of healthcare in ways that are both profound and immediate. CellVoyant, a spinout from the University of Bristol, is using AI and advanced imaging technology to solve one of the most persistent challenges in biotech: the cost, time, and complexity involved in developing cell therapies. Rafael explained how his team is applying real-time microscopy and predictive AI to monitor and guide cell behavior. This approach doesn't rely on invasive techniques that destroy the very cells being studied. Instead, it enables a clearer path forward in cell therapy development by understanding how cells behave and adapt over time. We explored several impactful examples, from CAR-T therapies for blood cancers to emerging treatments for Parkinson's disease and type 1 diabetes. Rafael drew comparisons to Google Maps, describing how CellVoyant's platform builds dynamic roadmaps for cell development, allowing scientists to correct course in real time. It's a shift in how we think about drug development, one that has the potential to lower costs and increase access to life-saving treatments. Beyond the science, Rafael shared his insights on the UK's biotech ecosystem, the role of academic spinouts, and why now is a strategic moment for the UK to establish itself as a global leader in AI-powered biotech. As political and economic conditions shift in other parts of the world, he sees a window of opportunity to attract talent, drive innovation, and strengthen commercialisation. So how far can AI go in transforming biotech, and what role will companies like CellVoyant play in making advanced therapies available to all? Tune in to find out.

In today's episode of You're Glowing, I'm pulling back the curtain on my morning routine—the one that's finally working and helping me feel more grounded, energized, and ready to take on the day (even with kids!). I also share a few things I've been loving lately, exciting new brand collabs, what I've been watching, and a breakdown of my Mother's Day Sale you don't want to miss. ✨ Want to feel your best—physically and mentally? This episode is for you, mama. Links from Today: Mothers Day Sale Dr. Browns Sippy Cup Reel Today's Sponsor: The Mother's Day Sale

Pour écouter mon podcast Choses à Savoir:Apple Podcast:https://podcasts.apple.com/fr/podcast/choses-%C3%A0-savoir-culture-g%C3%A9n%C3%A9rale/id1048372492Spotify:https://open.spotify.com/show/3AL8eKPHOUINc6usVSbRo3?si=e794067703c14028----------------------------La Chine bat son record de production de charbon… tout en annonçant une future taxe carbone nationale. Entre impératifs économiques et engagements climatiques, l'équilibre est fragile.Traduction :China breaks its coal production record—just as it pledges a future national carbon tax. A balancing act between growth and climate promises. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Did Greg do a cartwheel? Who runs out of gas?

Episode 265: Jay & Ray randomize some old idioms. - Encoreclear as a bellupset the apple cartSubscribe, review, and come find us on BlueSky, Insta, &  FB.Big Science Music is an award-winning original music and sound boutique. Providing scoring, sound design, radio, podcast, and all audio-post production services for the advertising, film, and video industries. Grab a taste of the groove salad at bigsciencemusic.comsome of the W9Y sources include phrase finder uk, word wizard forums, etymology online, the OED, American Dictionary of Idioms, Wiki, newspapers.com, stackexchange, worldwidewords.

   We have multiple lead stories today as the man arrested for bombing the Tesla dealership in KC is released from custody by a US judge in Boston and this is about to become a big national story.  Wait until you hear why this terrorist is back living with his parents.    In a shocking story, we learn John Elway was driving a golf cart Saturday in Palm Springs at a music festival when his friend and agent fell off and hit his head.  This story was unknown for four days... until Elway's friend died.  Now the Sheriff is investigating the incident.    A veteran pollster is in shock over the loyalty of Trump voters but I'm not.  It seems most of us put our country ahead of our own personal situation.  Of course we do.    Noah Cameron from St. Joseph made his Major League debut against the Rays and pitched a no-hitter into the 7th inning.  This is a great, great story but has a bit of a catch to it.   In Pittsburgh, a fan flips over a rail and falls. .  The fan is currently fighting for his life after earlier reports at the time of recording the podcast he had died.   A  former Patriots player thinks UNC should fire Bill Belichick, the Savannah Bananas are coming to KC and the Atlanta Falcons are fined for the Shedeur Sanders fiasco.

En el programa de hoy, Fernando Villegas y Nicole Rodríguez analizaron críticamente las primarias del oficialismo, cuestionando su legitimidad y calificándolas de farsas teatrales destinadas a proyectar una falsa unidad ideológica. Se debatió el significado de conceptos como derechos, libertades y meritocracia, criticando la inflación del gasto social sin resultados tangibles y la creciente burocratización estatal. También se discutió el poder de la CUT en la negociación del salario mínimo, denunciando su cercanía con el Partido Comunista. Finalmente, abordaron la decadencia tecnológica y autoritaria de regímenes como el chino y el soviético, destacando cómo la falta de libertad impacta negativamente en la innovación y el desarrollo. Para acceder al programa sin interrupción de comerciales, suscríbete a Patreon: https://www.patreon.com/elvillegas 00:02:10 - Primarias del oficialismo 00:10:07 - Derechos y libertades 00:22:40 - Impuestos y gasto social 00:32:00 - Meritocracia y educación 00:44:06 - Autoritarismo y tecnología 00:47:05 - CUT y salario mínimo

INTRO (00:23): Kathleen opens the show drinking a Beer Kitty Kolsch Ale from Devil's Canyon Brewing Company. She reviews her weekend doing shows in Napa, wine tasting, and exploring the Oxbow Farmer's Market.    TOUR NEWS: See Kathleen live on her “Day Drinking Tour.”   COURT NEWS (32:41): Kathleen shares the news that Stevie Nicks has a new album coming out in 2025, Jelly Roll has lost almost 200 lbs, and Snoop Dogg is set to host the Time 100 Special for ABC.    TASTING MENU (1:13): Kathleen samples Hidden Valley Ranch Bugles and Cheese Pizza Cheetos.    UPDATES (50:43): Kathleen shares updates on a Providence RI mall flipping into apartments for Gen Z'ers, Meghan Markle gets caught plagiarizing the Pearl book series, and Fyre Festival 2 is postponed again.   HOLY SHIT THEY FOUND IT (1:08:03 ): Kathleen reveals the discovery of four baby snow leopards in Pakistan, and a mystical harpy eagle thought to be extinct is found in Mexico.    FRONT PAGE PUB NEWS (1:10:25): Kathleen shares articles on Laguna Beach's recent enforcement of “quiet” pickleball paddles, the Pennsylvania town where Peeps are made is showcased, Florence Italy showcases an Easter tradition called the Explosion of the Cart, the 2nd Karen Read trial begins in Boston, New England might have a serial killer, Nostradamus predicts the next Pope, Nashville's Country Music Hall of Fame presents Taylor Swift's ERA's Tour artifacts, Martha Stewart trolls Katy Perry, and The Boss awakens from hibernation in Banff National Park.    WHAT ARE WE WATCHING (1:01:13 ): Kathleen recommends watching the NHL Stanley Cup Playoffs, and the Canadian golf course fight that went viral after being shared by Snoop Dogg.     FEEL GOOD STORY (1:34:51): Kathleen reads about a missing toddler lost in the Arizona wilderness who is lead to safety by a rancher's dog. 

In this episode of The Influence Factor, Alessandro Bogliari chats with Olivia Owens, Creator Partnerships and Business Development Lead at Teachable. Olivia shares her mission to empower creators through community, the launch of the 9 to 5 Quitters Club, and effective monetization strategies. She dives into Teachable's latest report on B2B creators, exploring how they build predictable income and the growing value of authentic storytelling in today's digital world.

It's The Week In IndyCar Listener Q&A show, which uses listener-driven comments and questions covering a variety of topics submitted by fans via social media. TOPICS: Indy Open Test, Penske's Long Beach learnings, explaining the various names for the cars and series...CART, IRL, Champ Car, IndyCar, Indy car, Championship Cars, and more! NEW show stickers and memorabilia: ThePruettStore.com EVERY episode is graciously supported by the Justice Brothers and TorontoMotorsports.com. If you'd like to join the PrueDay podcast listener group, send an email to pruedayrocks@gmail.com and you'll be invited to participate in the Discord chat that takes place every day and meet up with your new family at IndyCar events. Play on Podbean.com: https://marshallpruett.podbean.com/ Subscribe: https://marshallpruettpodcast.com/subscribe Join our Facebook Group: https://www.facebook.com/MarshallPruettPodcast [WTI]

The gals welcome Amanda from Live Laugh Larceny for some lively banter about the price of toes, a golden throne, a real circus show, a very dramatic runaway, sisterly love, buckets of beans, and unorthodox resting places. Tune in for April's episode of Gossip at the Corpse Cart! For a full list of show sponsors, visit https://wineandcrimepodcast.com/sponsors. To advertise on Wine & Crime, please email ad-sales@libsyn.com or go to advertising.libsyn.com/winecrime.